Inactive Instrument

Press Releases IceCure Medical Ltd TEL AVIV STOCK EXCHANGE

Equities

ICCM

IL0011224156

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company Showcase	05-20	PR
Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally	05-07	PR
IceCure Medical : Company Presentation	04-23	PU
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate, Data Submitted to FDA Requesting Marketing Authorization	04-16	AQ
IceCure Submits FDA Regulatory Filing for New XSense Cryoablation System with Cryoprobes	04-03	AQ
IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes	04-02	PR
IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024	03-27	PR
IceCure Medical Reports Positive Topline Results from ICE3 Cryoablation Breast Cancer Study	03-20	AQ
IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy	03-19	PR
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes	03-12	PR
IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech and Services Conference	03-08	AQ
IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference	03-07	PR
IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024	03-04	PR
Fourth BRIIT Conference in India Features IceCure's ProSense in Breast Cancer Imaging and Interventions Workshop	02-28	AQ
Study Using IceCure's ProSense Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer	02-27	AQ
Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop	02-27	PR
Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer	02-26	PR
IceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in Japan	02-15	PR
U.S. FDA Grants IceCure Medical's Appeal, Reopens De Novo Classification Request for Marketing Authorization of ProSense for Early-Stage Breast Cancer	01-31	AQ
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class	01-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IceCure Medical Ltd TEL AVIV STOCK EXCHANGE

Equities

ICCM

IL0011224156

Press Releases

Filters